Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

13 Jun, 2019, 12:30 BST Updates on Development of AMO Pharma's AMO-02 Presented at International Myotonic Dystrophy Consortium Meeting

AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited...


12 Jun, 2019, 13:38 BST CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA

CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, successfully...


12 Jun, 2019, 12:00 BST Alkermes Advances ALKS 4230 into Monotherapy Expansion Phase of ARTISTRY-1 in Patients With Renal Cell Carcinoma or Melanoma

Alkermes plc (Nasdaq: ALKS) today announced the initiation of the monotherapy expansion stage of its ARTISTRY-1 clinical trial to evaluate the...


11 Jun, 2019, 11:00 BST 29th EWMA Conference: Latest Clinical Data on Nexodyn® AOS Demonstrating Higher Healing Performance in Chronic Leg Ulcers Presented by Applied Pharma Research

APR Applied Pharma Research sa (APR) presented at the recent 29th conference of the European Wound Management Association (EWMA) in Göteborg, the...


11 Jun, 2019, 09:00 BST New Study Shows Rifaximin Significantly Reduced the Number and Length of Hospitalisations in Patients With Overt Hepatic Encephalopathy (HE) Awaiting Liver Transplatation

Rifaximin significantly reduced the incidence of all-cause hospital admissions in HE patients with advanced cirrhosis on the waiting list for liver...


11 Jun, 2019, 06:00 BST Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today announces that, following receipt of the Dutch investigating...


10 Jun, 2019, 16:11 BST Orion Biotechnology Announces Receipt of Pre-IND Guidance From the United States FDA on the Further Development of OB-002O as a Potential Treatment for Solid Tumours

Orion Biotechnology Canada Ltd., today announced that it has received feedback from the Food and Drug Administration (FDA) on a Pre-Investigational...


10 Jun, 2019, 13:05 BST First patients successfully treated in the Nuvaira AIRFLOW-3 COPD pivotal trial

Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, announced the first treatments in the AIRFLOW-3 pivotal trial, ...


10 Jun, 2019, 12:30 BST GT Biopharma Company Update

GT Biopharma, Inc. (OTCQB: GTBP) (OTCQB: GTBP.PA) an immuno-oncology company focused on innovative treatments based on the Company's proprietary NK...


10 Jun, 2019, 12:06 BST Proton Partners International: Protons to Play a Vital Role in the Battle Against Prostate Cancer

An upsurge in demand for proton beam therapy was predicted today as the centenary of the discovery of the proton was celebrated at a major scientific ...


10 Jun, 2019, 10:27 BST New Research Could Help Predict Seizures Before They Happen

A new study has found a pattern of molecules that appear in the blood before a seizure happens. This discovery may lead to the development of an...


10 Jun, 2019, 08:00 BST Menarini Ricerche at the 24ᵗʰ EHA Congress Presenting the First In Human Clinical Study of SEL24/MEN1703

Menarini Ricerche will present at the 24th EHA Congress 2019 in Amsterdam on the First In Human clinical trial of SEL24/MEN1703 (DIAMOND-01,...


10 Jun, 2019, 08:00 BST Sosei Heptares to Receive New $3 Million Milestone Payment from Pfizer, as It Advances a Second Candidate from the GPCR Collaboration for Clinical Development

Sosei Group Corporation ("the Company"); (TSE: 4565) and its strategic alliance partner Pfizer announce that a new clinical candidate from their...


06 Jun, 2019, 08:00 BST Spectrum Therapeutics Provides Update on Its Global Clinical Research Program and Unveils Pharmacovigilance

Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is...


06 Jun, 2019, 06:16 BST Nordic Nanovector to Present Preclinical Studies With 212Pb-NNV003, a Novel CD37-specific Targeted Alpha Therapy for CLL and NHL, at TRP 2019

Nordic Nanovector ASA (OSE: NANO) announces that its Chief Scientific Officer, Jostein Dahle, will present results from preclinical studies with...


05 Jun, 2019, 08:00 BST Vaccitech Universal Flu Vaccine Passes Phase 2b Clinical Development Milestones

Vaccitech Ltd. announces that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu...


05 Jun, 2019, 08:00 BST Launch of CIEMAR, the Largest Data Collection on Microwave Ablation in Patients With Liver Metastatic Disease

This European-wide observational study on the treatment of liver-only or liver-dominant metastatic disease in patients with colorectal adenocarcinoma ...


04 Jun, 2019, 11:49 BST mAPPing the New World of Allergy at EAACI Annual Congress 2019

The European Academy for Allergy and Clinical Immunology (EAACI) Annual Congress presents new avenues for controlling allergic rhinitis and asthma by ...


04 Jun, 2019, 08:38 BST Camurus Announces Publication of Phase 3 Study Results Showing Long-term Safety, Efficacy and High Rates of Patient Satisfaction With Buvidal®

Camurus announces that the leading drug dependence journal Addiction has today published full results from a 48-week, open-label, global Phase 3...


04 Jun, 2019, 07:38 BST New Interim Report at 30 Months and After Extra Injection Supports Long-term Effect of Intralymphatic Diamyd®

The first seven patients that have now been followed for the entire 30-month period in DIAGNODE-1 continue to show a positive clinical course and are ...


04 Jun, 2019, 07:00 BST Bluegrass Vascular Announces Enrollment Completion And Positive Results In U.S. Pivotal IDE Trial

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for...


03 Jun, 2019, 15:38 BST As ALK Prepares to Further Extend Their SLIT-tablet Portfolio, Tablet Formulation is Seen as Key in Delivering Consistent Positive Clinical Trial Results

Zydis® freeze-dried tablet technology used in ALK's SLIT-tablet range makes them faster dissolving than conventional compressed sublingual tablets in ...


03 Jun, 2019, 14:22 BST New Data from Oncopeptides Phase 1/2 O-12-M1 Trial Evaluating Melflufen in RRMM Presented at 2019 ASCO Annual Meeting

Oncopeptides AB (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat...


03 Jun, 2019, 14:09 BST BerGenBio Presents New Phase II Clinical Data That Bemcentinib in Combination With Low Dose Chemotherapy Improves Efficacy and Duration of Survival in Elderly AML Patients at ASCO 2019

Phase II trial evaluating bemcentinib in combination with low-intensity chemotherapy in elderly AML patients unfit for intensive therapy shows...